Dimed S.A. Distribuidora de Medicamentos (BVMF:PNVL3)
Brazil · Delayed Price · Currency is BRL 10.96
+0.08 (0.74%)
Jun 22, 2026, 5:04 PM GMT-3
BVMF:PNVL3 Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, BVMF:PNVL3 stock has a consensus rating of "Buy" and an average price target of R$17.60. The average 1-year stock price forecast is 60.58% higher than the current stock price, while the lowest is R$15.00 (+36.86%) and the highest is R$19.00 (+73.36%).
Price Target: R$17.60 (+60.58%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for BVMF:PNVL3 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Financial Forecast
Revenue This Year
6.30B
from 5.51B
Increased by 14.23%
Revenue Next Year
7.25B
from 6.30B
Increased by 15.10%
EPS This Year
1.17
from 0.90
Increased by 29.92%
EPS Next Year
1.41
from 1.17
Increased by 20.51%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is BRL.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 6.3B | ||
| Avg | 6.3B | ||
| Low | 6.3B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 15.1% | ||
| Avg | 14.2% | ||
| Low | 13.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.17 | ||
| Avg | 1.17 | ||
| Low | 1.17 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 29.9% | ||
| Avg | 29.9% | ||
| Low | 29.9% |